Discontinued — last reported Q3 '23

Other Income & Expense

Realized Gain (Loss) on Marketable Securities (Excl. OTTI)

Analysis

StatementIncome Statement
SectionOther Income & Expense
First reportedQ2 2022
Last reportedQ3 2023
Metric ID: is_c_realized_gain_loss_marketable_securities_ex_otti

Business Segments

View all
SegmentFY'25
MedTech$200.00M
Total

All segment values are derived from annual filings.